Cynthia Arbeeny

Cynthia Arbeeny

Company: Mitotherapeutix

Job title: CSO

Seminars:

MCJ siRNA: A Novel Metabolic Regulator for Treating Acute & Chronic Liver Diseases 3:30 pm

Identified MCJ/DNAJC15, a novel negative regulator of mitochondrial metabolism, which is highly expressed in liver, kidney and heart Knockdown is effective in treating acute and chronic liver diseases, including acute drug-induced injury, NAFLD/NASH, cholestatic liver disease and liver fibrosis Designed novel siRNA drug candidates and appropriate delivery technologies to target liver, and also kidney and…Read more

day: Track B Day 1 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.